Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

September 15, 2017

Presentation ESC 2017

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Presenter: Anselm K. Gitt

August 30, 2017

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Presentation

Reduction in Total CV Events With Ezetimibe-Simvastatin Post-ACS: IMPROVE-IT

Presenter: SA. Murphy

January 25, 2016

Presentation

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Presenter: Sune Nielsen

December 01, 2015

Presentation

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Presenter: K. Tsujita

July 28, 2015

Presentation SCCT 2015

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Presenter: Maros Ferencik

July 18, 2015

Presentation

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Presenter: Eliano Pio Navarese

March 10, 2014

Advertisement

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Reduction in Total CV Events With Ezetimibe-Simvastatin Post-ACS: IMPROVE-IT

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Impact of Dual Lipid Lowering With Ezetimibe and Atorvastatin on Plaque Regression in PCI Patients

Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT

Meta-analysis of Time-Related Benefits of Statin Therapy in Patients with ACS Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content